Your browser doesn't support javascript.
loading
Use of corneal cross-linking beyond keratoconus: a systemic literature review.
Manns, Richard P C; Achiron, Asaf; Knyazer, Boris; Elhaddad, Omar; Darcy, Kieran; Yahalomi, Tal; Tole, Derek; Avadhanam, Venkata S.
Afiliação
  • Manns RPC; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK.
  • Achiron A; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK.
  • Knyazer B; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Elhaddad O; Department of Ophthalmology, Soroka University Medical Center, The Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
  • Darcy K; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK.
  • Yahalomi T; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Tole D; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK.
  • Avadhanam VS; Department of Ophthalmology, Samson Assuta Ashdod Hospital and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Negev, Israel.
Graefes Arch Clin Exp Ophthalmol ; 261(9): 2435-2453, 2023 Sep.
Article em En | MEDLINE | ID: mdl-36881260
ABSTRACT

PURPOSE:

The success of corneal collagen cross-linking in altering keratoconus' clinical course has driven a search for further uses of this procedure. This literature review aims to analyze the scientific evidence available for the benefit of cross-linking in the management of ophthalmic diseases other than progressive keratoconus or ectasia induced by corneal refractive procedures.

METHODS:

A systemic literature review.

RESULTS:

We reviewed 97 studies. We found that collagen cross-linking can limit the progression of several other corneal ectasias, thus reducing and limiting the need for keratoplasty. Collagen cross-linking also can reduce the refractive power of the cornea and can be considered for a moderate degree of bacterial keratitis or when the organism is unidentified, which is refractive to antibiotics alone. However, the comparative rarity of these procedures has limited the extent of evidence. In fungal, Acanthamoeba, and herpes virus keratitis, the evidence is inconclusive of the safety and efficacy of cross-linking.

CONCLUSION:

Current clinical data is limited, and laboratory data has not fully correlated with published clinical data.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Ceratite Herpética / Ceratocone Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Graefes Arch Clin Exp Ophthalmol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Ceratite Herpética / Ceratocone Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Graefes Arch Clin Exp Ophthalmol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido